Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 63,250 | 27,762 | 106,140 | 74,785 | 43,407 |
| Depreciation Amortization | 377 | 179 | -6,766 | 2,090 | 1,801 |
| Income taxes - deferred | -21,126 | -7,162 | -29,493 | -25,821 | -16,964 |
| Accounts receivable | -12,714 | -20,395 | -10,066 | -3,569 | -1,496 |
| Accounts payable and accrued liabilities | 1,735 | -4,861 | 5,778 | 4,783 | -3,802 |
| Other Working Capital | -132 | -7,413 | 8,218 | 40,156 | 20,180 |
| Other Operating Activity | 33,554 | 35,646 | 53,228 | 28,728 | 25,117 |
| Operating Cash Flow | $64,944 | $23,756 | $127,039 | $121,152 | $68,243 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -68,792 | -9,014 | -328,748 | -298,846 | -88,815 |
| PPE Investments | -416 | N/A | -139 | -139 | -102 |
| Purchase Of Investment | N/A | N/A | 419,793 | 372,793 | 272,295 |
| Investing Cash Flow | $-69,208 | $-9,014 | $90,906 | $73,808 | $183,378 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,926 | 749 | 5,811 | 4,050 | 2,907 |
| Common Stock Repurchased | -3,954 | 464 | -145,428 | -145,428 | -145,428 |
| Other Financing Activity | -3,665 | -1,756 | -9,106 | -8,111 | -3,052 |
| Financing Cash Flow | $-2,693 | $-543 | $-148,723 | $-149,489 | $-145,573 |
| Exchange Rate Effect | -6 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 135,551 | 135,551 | 66,329 | 66,329 | 66,329 |
| End Cash Position | 128,588 | 149,750 | 135,551 | 111,800 | 172,377 |
| Net Cash Flow | $-6,963 | $14,199 | $69,222 | $45,471 | $106,048 |
| Free Cash Flow | |||||
| Operating Cash Flow | 64,944 | 23,756 | 127,039 | 121,152 | 68,243 |
| Capital Expenditure | -416 | 0 | -139 | -139 | -102 |
| Free Cash Flow | 64,528 | 23,756 | 126,900 | 121,013 | 68,141 |